Clinical Trial Update: Citalopram for Reflux Hypersensitivity and Functional Heartburn [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating citalopram for reflux hypersensitivity and functional heartburn in GERD patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: GERD | Phase 4 | Status: UNKNOWN